ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

Innovit and atrify Strengthen Partnership Accelerating Healthcare Manufacturers Ability to Manage and Share Accurate Product Content

By: PRLog

SAN FRANCISCO - June 3, 2022 - PRLog -- Innovit, the Product Information Management (PIM) specialists in enabling healthcare providers to deliver trusted data best practices in supply chain and clinical performance and atrify, a leading provider of product content solutions, announced today that they have strengthened their strategic partnership to accelerate global healthcare manufacturer's ability to leverage a full suite of content management solutions including UDI submissions, regulatory marketing, and supply chain needs.

Partners since 2015, Innovit and atrify have a proven track record of accomplishment with global healthcare customer engagements.

Today's announcement provides customers with the ability to leverage one solution for seamless and efficient compliance with regulatory demands and simplifies the mass distribution and syndication of accurate and up-to-date product information to improve online conversion.

Innovit and atrify's medical device manufacturer customers can now leverage a full PIM offering to manage regulatory and commercial product information, including UDI (Unique Device Identifier) submissions to EUDAMED (European Databank on Medical Devices), the FDA's Global Unique Device Identification Database (GUDID) and China's CUDID database for the registration of medical devices as well as sending content to GS1's Global Data Synchronization Network (GDSN).

"As global regulatory and omni-channel data use cases continue to evolve medical device manufacturers can leverage Innovit and atrify's joint solution to simplify the mass distribution and syndication of trustworthy product content," said Bang Chau, VP of Business Development at Innovit. "Innovit customers can capitalize on their investment in accurate product data and easily share this data to thousands of global trading parners via atrify's certified GDSN data pool."

"atrify is committed to advancing the management and syndication of product data and our global customers can now benefit from a broader solution set including Innovit's world-leading PIM and workflow automation services for healthcare and life sciences," said Arne Kuhlmann, Vice President of Marketing and Digital Business, atrify. "Pairing atrify's solution set and expertise in GS1 Global Data Syndication Network requirements with Innovit's leading compliance solutions streamlines and accelerates the speed to market for product content."

About Innovit
Innovit simplifies the process of managing, validating and exchanging trusted product data to enable regulatory compliance, reduce procurement spend and ensure patient safety. With over 20 years of experience in master data management and regulatory compliance, Innovit enables companies to easily share validated product data at a much lower cost. We have a proven track record in delivering 'globally scalable' product data management systems that enable Medical Device suppliers and Healthcare Providers to meet compliance deadlines, promote patient & consumer safety, while increasing supply chain efficiencies. Operating since 2000, Innovit is based in San Francisco with offices in London and Sydney, serving customers across the Healthcare and Life Science supply chains, such as Mayo Clinic, South Australia Health, Southern Cross Hospitals, 3M, Abbott, Arthrex, Ascensia Diabetes, B. Braun, Bio-Rad, Molnlycke, ThermoFisher, Zimmer Biomet.

About atrify
atrify is the leading provider for product content solutions that enables more than 20,000 users in over 50 countries to share accurate and reliable content with UDI Regulatory bodies (such as EUDAMED or GUDID) as well as their commercial trading partners and end-users such as doctors, nurses or patients. With dedicated expert services, atrify provides a holistic solution portfolio for transparency, regulatory compliance, and cross-channel trading.

Contact
Innvoit
***@innovit.com

Read Full Story - Innovit and atrify Strengthen Partnership Accelerating Healthcare Manufacturers Ability to Manage and Share Accurate Product Content | More news from this source

Press release distribution by PRLog

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.